Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001535610-21-000094
Filing Date
2021-08-30
Accepted
2021-08-30 08:30:41
Documents
1

Document Format Files

Seq Description Document Type Size
1 SABBY 13G PMCB 8.30.21 pmcb0821.txt SC 13G 11773
  Complete submission text file 0001535610-21-000094.txt   13517
Mailing Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653
Business Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653 (917) 595.2850
PharmaCyte Biotech, Inc. (Subject) CIK: 0001157075 (see all company filings)

EIN.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
Type: SC 13G | Act: 34 | File No.: 005-91495 | Film No.: 211221131
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 10 MOUNTAINVIEW ROAD SUITE 205 UPPER SADDLE RIVER NJ 07458
Business Address 10 MOUNTAINVIEW ROAD SUITE 205 UPPER SADDLE RIVER NJ 07458 646-307-4527
SABBY MANAGEMENT, LLC (Filed by) CIK: 0001535610 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G